Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BAART Programs, founded in 1977, is a leading provider of medication-assisted treatment (MAT) and behavioral health services for individuals struggling with opioid use disorder. As a brand under BayMark Health Services, BAART operates a network of over 30 clinics across the United States, offering a combination of FDA-approved medications like methadone and buprenorphine alongside comprehensive counseling. The organization also provides primary medical care, mental health services, and specialized support for pregnant women and veterans through its non-profit arm, BAART Community Healthcare. BAART is dedicated to delivering evidence-based, compassionate care in a nonjudgmental environment to help patients achieve long-term recovery and stability. The company's integrated approach addresses both the physical and psychological aspects of addiction while providing essential primary care services to underserved populations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BAART Community Healthcare.